VARILRIX Trademark

Trademark Overview

On Thursday, October 13, 2016, a trademark application was filed for VARILRIX with the United States Patent and Trademark Office. The USPTO has given the VARILRIX trademark a serial number of 79196496. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, January 26, 2024. This trademark is owned by Glaxosmithkline Biologicals S.A.. The VARILRIX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for human use
varilrix

General Information

Serial Number79196496
Word MarkVARILRIX
Filing DateThursday, October 13, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, January 26, 2024
Registration Number5238772
Registration DateTuesday, July 11, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 25, 2017

Trademark Statements

Description of MarkThe mark consists of the literal element "VARILRIX" in green with the design of an orange triangle above the letter "I", and the design of a triangle composed of orange triangles. The color white is background.
Goods and ServicesVaccines for human use
Indication of Colors claimedThe color(s) green and orange is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, January 26, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxosmithkline Biologicals S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBE
Party NameGlaxosmithkline Biologicals S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBE
Party NameGlaxosmithkline Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBE

Trademark Events

Event DateEvent Description
Saturday, November 26, 2016APPLICATION FILING RECEIPT MAILED
Thursday, November 17, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 22, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, December 13, 2016ASSIGNED TO EXAMINER
Friday, December 16, 2016NON-FINAL ACTION WRITTEN
Saturday, December 17, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, December 20, 2016REFUSAL PROCESSED BY MPU
Tuesday, December 20, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 6, 2017REFUSAL PROCESSED BY IB
Wednesday, March 15, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 25, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, October 12, 2017FINAL DISPOSITION PROCESSED
Thursday, October 12, 2017FINAL DISPOSITION NOTICE SENT TO IB
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 3, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, April 5, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 25, 2017PUBLISHED FOR OPPOSITION
Wednesday, October 11, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Monday, July 11, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, August 3, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 3, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 3, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 3, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, August 3, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 3, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, January 26, 2024CANCELLED SECTION 71
Thursday, October 3, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Thursday, October 3, 2024INVALIDATION PROCESSED
Saturday, October 26, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Friday, September 27, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

Related Keywords

varilrix human vaccines